SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-098777
Filing Date
2024-09-11
Accepted
2024-09-11 08:00:23
Documents
15
Period of Report
2024-09-11
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2422910d5_8k.htm   iXBRL 8-K 27434
2 EXHIBIT 99.1 tm2422910d5_ex99-1.htm EX-99.1 8434
6 GRAPHIC tm2422910d5_ex99-1img001.jpg GRAPHIC 12942
  Complete submission text file 0001104659-24-098777.txt   230581

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA alim-20240911.xsd EX-101.SCH 3036
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE alim-20240911_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alim-20240911_pre.xml EX-101.PRE 22373
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2422910d5_8k_htm.xml XML 3681
Mailing Address 6310 TOWN SQUARE SUITE 400 ALPHARETTA GA 30005
Business Address 6310 TOWN SQUARE SUITE 400 ALPHARETTA GA 30005 678-990-5740
ALIMERA SCIENCES INC (Filer) CIK: 0001267602 (see all company filings)

IRS No.: 200028718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34703 | Film No.: 241291451
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)